RAMP3 and hepatocellular carcinoma: Idarubicin is not only the most toxic drug to human hepatocellular carcinoma cell lines, but also has the ability to overcome multidrug resistance (38, 39), suggesting to us the possibility of RAMP3 being a drug target.